ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
다우존스 지수
40,003.59
0.34%
Bitcoin
67,005.49
0.10%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Compass Therapeutics Inc (CMPX)

  7. Compass Therapeutics Inc (CMPX) 뉴스

CMPX

Compass Therapeutics (CMPX)

Compass Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CMPX
일자시간출처헤드라인심볼기업
2024/05/1421:00GlobeNewswire Inc.Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:CMPXCompass Therapeutics Inc
2024/05/1321:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMPXCompass Therapeutics Inc
2024/05/1321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
2024/05/1321:00GlobeNewswire Inc.Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
2024/04/2521:00GlobeNewswire Inc.Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the Treatment of Patients with Metastatic or Locally Advanced Biliary Tract Tumors That Have Been Previously TreatedNASDAQ:CMPXCompass Therapeutics Inc
2024/04/1621:00GlobeNewswire Inc.Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid TumorsNASDAQ:CMPXCompass Therapeutics Inc
2024/04/1221:00GlobeNewswire Inc.Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual ConferenceNASDAQ:CMPXCompass Therapeutics Inc
2024/04/1021:00GlobeNewswire Inc.Compass Therapeutics to Participate in the Stifel Targeted Oncology DaysNASDAQ:CMPXCompass Therapeutics Inc
2024/04/1001:00GlobeNewswire Inc.Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CMPXCompass Therapeutics Inc
2024/03/2122:00GlobeNewswire Inc.Compass Therapeutics Reports 2023 Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
2024/03/1123:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
2024/02/2922:00GlobeNewswire Inc.Compass Therapeutics to Participate in the Leerink Partners Global Biopharma ConferenceNASDAQ:CMPXCompass Therapeutics Inc
2024/02/2822:00GlobeNewswire Inc.Compass Therapeutics Announces Publication of CTX-8371 Preclinical Data in OncoImmunology, its Bispecific Antibody Checkpoint Inhibitor, now Advancing to First-in-Human Clinical TrialNASDAQ:CMPXCompass Therapeutics Inc
2024/02/1502:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
2024/02/1002:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
2024/01/1100:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
2024/01/1007:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
2024/01/0522:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
2024/01/0522:00GlobeNewswire Inc.Compass Therapeutics Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
2023/11/2204:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
2023/11/0921:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMPXCompass Therapeutics Inc
2023/11/0921:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
2023/11/0921:30GlobeNewswire Inc.Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
2023/11/0722:00GlobeNewswire Inc.Compass Therapeutics to Participate in Upcoming Investor EventsNASDAQ:CMPXCompass Therapeutics Inc
2023/08/3021:00GlobeNewswire Inc.Compass Therapeutics to Participate in Upcoming Investor EventsNASDAQ:CMPXCompass Therapeutics Inc
2023/08/0321:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMPXCompass Therapeutics Inc
2023/08/0321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
2023/08/0321:00GlobeNewswire Inc.Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
2023/06/2305:05GlobeNewswire Inc.Compass Therapeutics to be Added to the Russell 2000® and Russell 3000® IndexesNASDAQ:CMPXCompass Therapeutics Inc
2023/06/0123:06GlobeNewswire Inc.Compass Therapeutics to Participate in Upcoming Investor EventsNASDAQ:CMPXCompass Therapeutics Inc
 검색 관련기사 보기:NASDAQ:CMPX

최근 히스토리

COIN
GLSEUR
LATK
PRMUSDT
Primal
BIT
F19190
Vontobel Financial Produ...
BIT
UB03T3
UniCredit Bank
BOV
BBASQ482
BBASQ482 Ex:23,09
EU
1731T
1731T
NASDAQ
HSIDX
Hartford Schroders Susta...
EU
9919T
9919T
COIN
DELIZEUR
NEO
QIF
AGF Systematic Global In...
AMEX
LSQ.D
KOSPI
072130
유엔젤
TSXV
ANL.H@OL
BIT
UB3JUT
UniCredit Bank
ASX
RWCKOA
HITB
KAVABTC
Kava BEP2 Token
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유